194 related articles for article (PubMed ID: 19213607)
1. Transperineal injection of hyaluronic acid in the anterior perirectal fat to decrease rectal toxicity from radiation delivered with low-dose-rate brachytherapy for prostate cancer patients.
Prada PJ; Gonzalez H; Menéndez C; Llaneza A; Fernández J; Santamarta E; Ricarte PP
Brachytherapy; 2009; 8(2):210-217. PubMed ID: 19213607
[TBL] [Abstract][Full Text] [Related]
2. Transperineal injection of hyaluronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity modulated brachytherapy or EBRT for prostate cancer patients.
Prada PJ; Fernández J; Martinez AA; de la Rúa A; Gonzalez JM; Fernandez JM; Juan G
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):95-102. PubMed ID: 17707267
[TBL] [Abstract][Full Text] [Related]
3. High-dose-rate interstitial brachytherapy as monotherapy in one fraction and transperineal hyaluronic acid injection into the perirectal fat for the treatment of favorable stage prostate cancer: treatment description and preliminary results.
Prada PJ; Jimenez I; González-Suárez H; Fernández J; Cuervo-Arango C; Mendez L
Brachytherapy; 2012; 11(2):105-10. PubMed ID: 21917528
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric implications of an injection of hyaluronic acid for preserving the rectal wall in prostate stereotactic body radiation therapy.
Chapet O; Udrescu C; Tanguy R; Ruffion A; Fenoglietto P; Sotton MP; Devonec M; Colombel M; Jalade P; Azria D
Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):425-32. PubMed ID: 24411613
[TBL] [Abstract][Full Text] [Related]
5. Transperineal injection of hyaluronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity-modulated brachytherapy or EBRT for prostate cancer patients: in regard to Prada et al. (Int J Radiat Oncol Biol Phys 2007;69:95-102.).
Vordermark D; Guckenberger M; Baier K; Markert K
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):316-7. PubMed ID: 18406899
[No Abstract] [Full Text] [Related]
6. Predictive factors of long-term rectal toxicity following permanent iodine-125 prostate brachytherapy with or without supplemental external beam radiation therapy in 2216 patients.
Tanaka T; Yorozu A; Sutani S; Yagi Y; Nishiyama T; Shiraishi Y; Ohashi T; Hanada T; Saito S; Toya K; Shigematsu N
Brachytherapy; 2018; 17(5):799-807. PubMed ID: 29936128
[TBL] [Abstract][Full Text] [Related]
7. The effect of obesity on rectal dosimetry after permanent prostate brachytherapy.
Patil N; Crook J; Saibishkumar EP; Aneja M; Borg J; Pond G; Ma C
Brachytherapy; 2009; 8(2):218-222. PubMed ID: 19230790
[TBL] [Abstract][Full Text] [Related]
8. Cross-linked hyaluronan gel reduces the acute rectal toxicity of radiotherapy for prostate cancer.
Wilder RB; Barme GA; Gilbert RF; Holevas RE; Kobashi LI; Reed RR; Solomon RS; Walter NL; Chittenden L; Mesa AV; Agustin J; Lizarde J; Macedo J; Ravera J; Tokita KM
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):824-30. PubMed ID: 20510195
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronic acid spacer in focal prostate reirradiation: A single centre experience.
Ozyigit G; Hurmuz P; Akinci D; Esen SCB; Yilmaz MT; Akdogan B; Akyol FH
Cancer Radiother; 2020 Dec; 24(8):805-811. PubMed ID: 32565071
[TBL] [Abstract][Full Text] [Related]
10. Prostate hypofractionated radiation therapy with injection of hyaluronic acid: acute toxicities in a phase 2 study.
Chapet O; Decullier E; Bin S; Faix A; Ruffion A; Jalade P; Fenoglietto P; Udrescu C; Enachescu C; Azria D
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):730-6. PubMed ID: 25752385
[TBL] [Abstract][Full Text] [Related]
11. A dosimetric study of polyethylene glycol hydrogel in 200 prostate cancer patients treated with high-dose rate brachytherapy±intensity modulated radiation therapy.
Strom TJ; Wilder RB; Fernandez DC; Mellon EA; Saini AS; Hunt DC; Pow-Sang JM; Spiess PE; Sexton WJ; Poch MA; Biagioli MC
Radiother Oncol; 2014 Apr; 111(1):126-31. PubMed ID: 24746567
[TBL] [Abstract][Full Text] [Related]
12. Prostate hypofractionated radiation therapy: injection of hyaluronic acid to better preserve the rectal wall.
Chapet O; Udrescu C; Devonec M; Tanguy R; Sotton MP; Enachescu C; Colombel M; Azria D; Jalade P; Ruffion A
Int J Radiat Oncol Biol Phys; 2013 May; 86(1):72-6. PubMed ID: 23290444
[TBL] [Abstract][Full Text] [Related]
13. Morbidity effect of the time gap between supplemental beam radiation and Pd-103 prostate brachytherapy.
Corriveau J; Wallner K; Merrick G; True L; Cavanagh W; Sutlief S; Butler W
Brachytherapy; 2003; 2(2):108-13. PubMed ID: 15062149
[TBL] [Abstract][Full Text] [Related]
14. Technique of Injection of Hyaluronic Acid as a Prostatic Spacer and Fiducials Before Hypofractionated External Beam Radiotherapy for Prostate Cancer.
Boissier R; Udrescu C; Rebillard X; Terrier JE; Faix A; Chapet O; Azria D; Devonec M; Paparel P; Ruffion A
Urology; 2017 Jan; 99():265-269. PubMed ID: 27725233
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer.
Zelefsky MJ; Wallner KE; Ling CC; Raben A; Hollister T; Wolfe T; Grann A; Gaudin P; Fuks Z; Leibel SA
J Clin Oncol; 1999 Feb; 17(2):517-22. PubMed ID: 10080594
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneous spacer injection to reduce skin toxicity in breast brachytherapy: A pilot study on mastectomy specimens.
Struik GM; Pignol JP; Kolkman-Deurloo IK; Godart J; Verduijn GM; Koppert LB; Birnie E; Ghandi A; Klem TM
Brachytherapy; 2019; 18(2):204-210. PubMed ID: 30528494
[TBL] [Abstract][Full Text] [Related]
17. Perirectal seeds as a risk factor for prostate brachytherapy-related rectal bleeding.
Mueller A; Wallner K; Merrick G; Ford E; Sutlief S; Cavanagh W; Butler W
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1047-52. PubMed ID: 15234038
[TBL] [Abstract][Full Text] [Related]
18. Comparison of acute and subacute genitourinary and gastrointestinal adverse events of radiotherapy for prostate cancer using intensity-modulated radiation therapy, three-dimensional conformal radiation therapy, permanent implant brachytherapy and high-dose-rate brachytherapy.
Morimoto M; Yoshioka Y; Konishi K; Isohashi F; Takahashi Y; Ogata T; Koizumi M; Teshima T; Bijl HP; van der Schaaf A; Langendijk JA; Ogawa K
Tumori; 2014; 100(3):265-71. PubMed ID: 25076236
[TBL] [Abstract][Full Text] [Related]
19. Combined brachytherapy with external beam radiotherapy for localized prostate cancer: reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy.
Zelefsky MJ; Nedelka MA; Arican ZL; Yamada Y; Cohen GN; Shippy AM; Park JJ; Zaider M
Brachytherapy; 2008; 7(1):1-6. PubMed ID: 18299108
[TBL] [Abstract][Full Text] [Related]
20. Long term results of a prospective dose escalation phase-II trial: interstitial pulsed-dose-rate brachytherapy as boost for intermediate- and high-risk prostate cancer.
Lettmaier S; Lotter M; Kreppner S; Strnad A; Fietkau R; Strnad V
Radiother Oncol; 2012 Aug; 104(2):181-6. PubMed ID: 22853851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]